Find Academic Supervisors

Brian W. Pogue, Ph.D., is the Robert A. Pritzker Chair in Biomedical Engineering at Dartmouth College's Thayer School of Engineering, with a joint appointment as an Honorary Fellow in Medical Physics at the University of Wisconsin-Madison. His academic background includes a Ph.D. in Medical/Nuclear Physics from McMaster University and a Research Fellowship at Harvard Medical School's Wellman Center for Photomedicine. He has led significant administrative roles, including Dean of Graduate Studies at Dartmouth (2008–2012) and Chair of Medical Physics at Wisconsin (2022–2025). Research Focus : Dr. Pogue pioneers Optics in Medicine , specializing in cancer imaging, photodynamic therapy, and surgical guidance. His work integrates fluorescence imaging, radiation therapy monitoring, and molecular diagnostics to improve cancer treatment precision. Key innovations include Cherenkov imaging for radiotherapy dosimetry and hypoxia-sensitive probes for tumor resection. Publication Trends : Recent articles (2023–2025) emphasize real-time surgical guidance, hypoxia quantification, and multimodal imaging systems. Dominant themes include fluorescence tomography, radiation dosimetry, and low-cost diagnostic devices, reflecting a translational focus from preclinical validation to clinical applications. Awards & Honors : Fellow, Optica (formerly OSA) Fellow, American Institute for Medical and Biological Engineering (AIMBE) Fellow, American Association of Physicists in Medicine (AAPM) Fellow, SPIE (International Society for Optics and Photonics) Funding & Innovation : Continuously funded by the NIH since 2001 ($52M+ total), Dr. Pogue founded three startups: DoseOptics LLC (radiotherapy dose imaging) and Hypoxia Surgical LLC (tissue hypoxia cameras), bridging academic research to clinical tools.

• Optics in Medicine
• Cancer Imaging
• Photodynamic Therapy
• +5 more

Dr. Arthur F. Petusseau is a biomedical optics researcher specializing in fluorescence-guided surgery, hypoxia imaging, and radiation therapy monitoring. His work focuses on developing advanced optical imaging techniques for tumor detection, oxygen quantification, and surgical navigation. Key affiliations: Collaborator with experts like Brian Pogue, Petr Bruza, and Marien Ochoa Institutional affiliation not explicitly stated in provided text Research Interests: Dr. Petusseau's work spans biomedical optics, surgical imaging, and tumor oxygenation analysis. He develops technologies leveraging porphyrin-based fluorescence, single-photon sensors, and real-time oxygen mapping to improve cancer treatment outcomes. Recent Publications: His research includes time-of-flight fluorescence imaging for tumor depth assessment, delayed fluorescence signal processing for hypoxia quantification, and Cherenkov imaging for radiation therapy monitoring. Keywords across his work include Photodynamic Therapy , Radiotherapy , SPAD Sensors , and Biological Imaging . Technical Innovations: Notable contributions include the PRESTO non-invasive skin lesion detection tool and pressure-enhanced tissue oxygen sensing. His 2025 work on deep learning-enhanced fluorescence reconstruction demonstrates cutting-edge computational applications in surgical imaging.

• Biomedical Optics
• Medical Imaging
• Oncology
• +3 more

Prof. Kimberley S. Samkoe is an Associate Professor at Dartmouth College with a focus on biomedical optics, molecular imaging, and cancer research. Her work spans fluorescence-guided surgery, photodynamic therapy (PDT), and quantitative imaging techniques for tumor margin assessment and therapeutic monitoring. Academic Affiliation: Dartmouth College Key Research Areas: Fluorescence Imaging, Paired-Agent Imaging, Head and Neck Cancer, Skin Cancer, Photodynamic Therapy, Biomedical Imaging Systems Her research emphasizes fluorescence molecular imaging for tumor margin assessment, paired-agent imaging to quantify drug distribution, and image-guided surgical tools . Recent publications highlight innovations in intraoperative fluorescence ratio approaches , quantitative biodistribution , and clinical translation of imaging technologies . Key trends in her 15 most recent articles include: Development of 3D-printed optical phantoms for clinical validation Integration of multispectral imaging for immune receptor quantification Advancements in PDT dosimetry and radiometric imaging platforms

• Biomedical Optics
• Molecular Imaging
• Cancer Research
• +7 more

Caroline Maake is an Adjunct Professor at the Institute of Anatomy , University of Zurich, with a career spanning over three decades. She has been recognized as Teacher of the Year (2009, 2012), a Goldene Lehr-Lorbeere recipient (2019), and the CS Award for Best Teaching (2023). Education: MD in human medicine from Johannes Gutenberg University Mainz (1994) Research Interests: Focus on photodynamic therapy , nanomedicine , hyperthermia , and intercultural approaches in medicine . Her recent publications (2021-2025) demonstrate interdisciplinary work across pharmacology , oncology , ethnobotany , and medical engineering . Key trends include plant-based anti-inflammatory agents , photothermal cancer treatments , Indigenous Amazonian medicine , and innovative surgical devices . Notable collaborations with institutions like the University of Manitoba and University of Erlangen further highlight her international impact. Scientific Awards: Teacher of the Year (2009, 2012) Goldene Lehr-Lorbeere (2019) CS Award Best Teaching (2023) Active in both basic research and clinical translation , her work bridges biomedical engineering , traditional medicine , and modern cancer therapies . She has contributed to over 44 PubMed-indexed publications since 2002, covering topics from bladder pathophysiology to network pharmacology .

• Photodynamic Therapy
• Nanomedicine
• Hyperthermia
• +7 more

Melis Özkan is a Doctoral Assistant affiliated with the School of Engineering (STI) at École Polytechnique Fédérale de Lausanne (EPFL). She holds dual roles in the Supramolecular Nanomaterials and Interfaces Laboratory (SUNMIL) under the Constellium Chair and the Bertarelli Foundation Chair in Translational Neuroengineering (TNE) . She is enrolled in the Doctoral Program in Materials Science and Engineering (EDMX) within EPFL's doctoral school (EDOC). Her research focuses on supramolecular nanomaterials, biomaterials design, and neuroengineering applications , with a particular emphasis on antimicrobial coatings, drug delivery systems, and regenerative biomaterials for peripheral nerve repair. Her academic journey includes work on photoactive materials for photodynamic therapy, sustainable polymers for chemical recycling, and the integration of physical stimuli with nanostructured materials to enhance cellular regeneration. Key areas of exploration include glycosaminoglycan mimetics for antiviral activity, lignin-based antiviral coatings, and electro-viscoelastic migration in microfluidic systems. Melis Özkan's research outputs span biomedical engineering, materials science, and nanomedicine , with notable contributions to the development of multifunctional molecular platforms and hybrid nanoparticles for combined therapeutic applications. Her work bridges fundamental chemistry with translational engineering, aiming to address challenges in infectious disease treatment and tissue regeneration. No academic awards or grants are explicitly listed in the provided information. She is actively involved in lab activities at both the SUNMIL (Lausanne) and TNE (Geneva) facilities, contributing to interdisciplinary projects at EPFL's advanced research hubs.

• Materials Science
• Nanomedicine
• Biomaterials
• +4 more

Professor Yvonne Achermann is a medical doctor specialized in internal medicine and infectious diseases. She currently serves as Senior Physician in the Department of Internal Medicine and Infectious Diseases at Zollikerberg Hospital and previously held positions at University Hospital Zurich. She has a Venia legendi (Habilitation) from the Clinic for Infectious Diseases and Hospital Hygiene at University Hospital Zurich, establishing her academic credentials. Her scientific focus since 2008 has been on implant-associated infections, particularly prosthetic joint infections. She has been involved in numerous clinical and epidemiological studies with experts including Markus Vogt, Andrej Trampuz, and Werner Zimmerli. Her research spans biofilm infections caused by Staphylococcus aureus and Cutibacterium acnes, with emphasis on developing diagnostic methods and prevention strategies for orthopedic implant infections. Since 2020, she has led a research group with PD Dr. Philipp Bosshard on 'Photodynamic treatment to prevent and treat periprosthetic joint infections,' investigating how photodynamic therapy (PDT) improves biofilm eradication through bacterial killing on prosthetic joint implants without altering materials. Her work combines laboratory research with humanized preclinical models and clinical applications through multi-disciplinary collaborations with institutions including University Hospital Balgrist and the University of Applied Sciences and Arts Northwestern Switzerland. Her publication record demonstrates growing expertise in orthopedic infections, with recent focus on improving diagnostic sensitivity for implant-associated infections and developing novel treatment options for skin pathogens in orthopedic surgery. Her research integrates molecular diagnostics, microbiology, and clinical applications to address critical challenges in infection prevention. Award of the Swiss Society of Hospital Hygiene & the Swiss Society for Infectious Diseases (2010) Swiss National Science Foundation (SNF) Fellowship Dr. Achermann has served as an infectious diseases consultant at major Zurich medical institutions including University Hospital Balgrist and Clinic Schulthess. Her research has been supported by the University of Zurich's 'filling the gap' program, enabling continuation of her work on diagnostic and prevention strategies for implant-associated infections. Her research group innovates in preventing and treating postoperative orthopedic infections through pioneering photodynamic therapy approaches and advanced diagnostics. They focus on three main areas: improving skin antisepsis to prevent deep orthopedic implant infections, developing diagnostic tests for better sensitivity with explanted foreign materials, and studying novel intra-operative treatment options for skin pathogens infecting foreign materials in orthopedic surgery.

• Implant-associated infections
• Prosthetic joint infections
• Biofilm infections
• +7 more

Peter Sander is a Full Professor at the University of Zurich , leading the Institute of Medical Microbiology 's research group focused on Mycobacterium tuberculosis and Mycobacterium abscessus . His research spans virulence mechanisms, lipoprotein biogenesis, vaccine innovation, and antibiotic resistance. Key research areas include Posttranslational modification of mycobacterial lipoproteins Drug susceptibility and resistance mechanisms RNA metabolism as antibiotic target Recent publications highlight advancements in 3',6'-disubstituted spectinomycins for efflux resistance, Fidaxomicin derivatives with enhanced activity, and Mycobacterium abscessus resistance gene characterization. Collaborations span institutions in Switzerland, France, Italy, and the U.S. Scientific honors include the Young Investigator Award from the German Society for Hygiene and Microbiology (2002). Supported by grants from the Swiss National Science Foundation, European Commission, and industry partners. Students mentored include Ph.D. candidates at the University of Zurich. His lab investigates lipoprotein synthesis pathways and host immunity interactions , with implications for tuberculosis and nontuberculous mycobacteria therapies.

• Mycobacterium tuberculosis Research
• Antibiotic Resistance Mechanisms
• Vaccine Development
• +3 more

Dr. Sandrine Gerber is an Adjunct Professor at the École Polytechnique Fédérale de Lausanne (EPFL) in the School of Basic Sciences and Deputy Director of the Institute of Chemical Sciences and Engineering. She leads research in biomaterials engineering and nanomedicine, with particular focus on functionalized polymers for therapeutic applications. Her laboratory develops alginate-based hydrogels for cell transplantation and functionalized nanoparticles for targeted drug/gene delivery. Research domains include: Design of polysaccharide-based hydrogels for islet/hepatocyte transplantation Surface modification of harmonic nanoparticles for cancer theranostics Chitosan copolymers for gene delivery in metabolic diseases Functional biomaterials for tissue engineering scaffolds Her publication portfolio demonstrates strong emphasis on nanomaterial functionalization strategies, with recent work focusing on biosensor interfaces, lithium niobate nanoparticles for imaging, and COVID-19 therapeutic formulations. She serves on committees for the Doctoral Program in Chemistry and Chemical Engineering and contributes to EPFL's educational programs in organic chemistry. Scientific honors include the Werner Prize (2010) and Excellence in Teaching Award (2018). She has supervised 15+ PhD candidates and numerous master's students in biomaterials and synthetic chemistry.

• Organic Synthesis
• Biomaterials Engineering
• Nanomedicine
• +3 more

Prof. Dr. Yoko Yamakoshi is a Lecturer at the Department of Chemistry and Applied Biosciences at ETH Zürich, leading the Gruppe Yamakoshi. Her research focuses on fullerene chemistry, photodynamic therapy, and nanomaterials for biomedical applications. She specializes in designing water-soluble fullerene conjugates for targeted drug delivery and imaging, particularly in atherosclerosis diagnostics and cancer therapy. Her work emphasizes reactive oxygen species (ROS) generation mechanisms, enzyme-responsive materials, and AFM-based single-molecule studies. Notable contributions include LDL-mimetic nanoparticles for MRI contrast enhancement and tripod-C60 functionalized AFM tips for DNA origami manipulation. Yamakoshi's interdisciplinary approach spans materials science, biochemistry, and medical imaging. Recent research highlights include conditionally activated ROS probes for cancer diagnostics, fullerene-peptide conjugates with enhanced photocytotoxicity, and Gd(III)-porphyrin complexes for dual MRI/photodynamic applications. Her lab actively explores fullerene derivatives' structural properties and their implications for biological and nanotechnological uses.

• Fullerene chemistry
• Photodynamic therapy
• Nanomaterials
• +5 more

Dr. Maxim Yulikov is a Lecturer at the Department of Chemistry and Applied Biosciences, ETH Zurich, Switzerland. He is affiliated with the Institute of Molecular Physical Sciences (IMPS), focusing on advanced spectroscopic techniques and biomolecular studies. His research integrates electron paramagnetic resonance (EPR) spectroscopy, dynamic nuclear polarization (DNP), and molecular modeling to explore structural dynamics of biomolecules, heterogeneous materials, and functional nanomaterials. Key affiliations: ETH Zurich, IMPS Expertise: EPR spectroscopy, DNP, biomolecular structure analysis, nanomedicine His work emphasizes developing novel spin labels, optimizing DNP sensitivity, and studying protein-RNA interactions, dietary fibers, and phase-separated biomolecular condensates. Recent projects include designing Gd(III) spin labels, investigating copper interactions with biomolecules, and enhancing NMR sensitivity through tailored biradicals. Publications highlight contributions to RIDME spectroscopy, heterogeneous systems analysis, and materials chemistry. He teaches 529-0053-00L Polymer Physics Methods for Unstructured Biomolecules in the Fall semester 2025.

• Electron Paramagnetic Resonance (EPR) Spectroscopy
• Biomolecular Structure Analysis
• Dynamic Nuclear Polarization (DNP)
• +3 more

Dr. Marie-Noëlle Giraud is a part-time lecturer and senior assistant at the Department of Medicine, University of Fribourg, specializing in cardiovascular regeneration and tissue engineering. She leads the Heart Repair & Regeneration Laboratory and investigates cell-biomaterial interactions, paracrine effects of engineered tissues, and inflammation's role in cardiac repair through animal models. Focus on myocardial and vessel regeneration using cell-based therapies and biomaterials Develops biological bandages containing cells and matrices for cardiac repair Studies macrophage polarization in cardiac repair mechanisms Investigates endurance training's impact on post-MI recovery Researches bioresorbable polymeric stents for coronary artery disease Her recent publications emphasize vascular injury models, bioreactor systems, and biomaterial development for cardiovascular applications. The laboratory employs advanced techniques in 3D cell culture, echocardiography, and histological analysis.

• Cardiovascular Regeneration
• Biomaterials
• Myocardial Repair
• +3 more

Georges Wagnières is a Professor at the École Polytechnique Fédérale de Lausanne (EPFL) in the School of Basic Sciences (SB), Department of Physics (IPHYS), leading the LIFMET laboratory. He holds roles in multiple educational entities within EPFL, including SCGC, SPH, and SSV. His research focuses on biomedical optics, photodynamic therapy (PDT), photobiomodulation, and technology transfer. He co-founded Medlight SA, a spin-off developing light delivery systems for PDT. Education: MSc in Physics from the University of Lausanne (1986), PhD in Biomedical Optics from EPFL (1992), postdoc at Harvard (1993-1994), and an Executive Master in Technology Management from HEC Lausanne (2001). Research interests include fluorescence spectroscopy/imaging, PDT for cancer and inflammatory diseases, oxygen measurement in tissues, and mitochondrial modulation for neurodegenerative diseases. He has supervised 12 PhD students and teaches courses in biomedical optics, photomedicine, and general physics. Publications: Over 235 articles, including 150 in peer-reviewed journals, and 18 patents. His work bridges preclinical/clinical development of photosensitizers and optical devices, with applications in oncology and vascular disorders.

• Biomedical Optics
• Photodynamic Therapy
• Photobiomodulation
• +6 more

Prof. Christian Adlhart is a Professor at the ZHAW School of Life Sciences and Facility Management, leading the Functional Materials and Nanotechnology Network. His research focuses on nanomaterials, biomedical engineering, and environmental applications, with a strong emphasis on nanofiber-based materials. He has led numerous projects, including advancements in antimicrobial coatings, biocompatible implants, and nanofiber aerogels for filtration and medical applications. His work bridges materials science and biotechnology, addressing challenges in regenerative medicine, environmental remediation, and healthcare innovation. Key roles include project leadership in initiatives like AMiCI (anti-microbial coatings) and tPDT (photodynamic therapy). He is affiliated with networks like COST Action MP1206 (electrospinning) and holds an ORCID identifier (0000-0002-4081-221X). His recent publications explore topics such as cellulose nanofiber sponges, supercritical drying of nanofibers, and SARS-CoV-2 prevention materials. Research interests span nanofiber fabrication, biomedical applications, and sustainable materials. His lab develops advanced filtration systems, biocompatible scaffolds, and functional coatings. He has contributed to over 50 peer-reviewed articles and holds patents in gas extraction devices and catalytic processes.

• Nanomaterials
• Biomedical Engineering
• Environmental Science
• +3 more

Dr. David Kodr is a Researcher affiliated with the Laboratory of Organic Chemistry (LOC) at ETH Zürich, Switzerland, under the Professorship for Organic Chemistry. He specializes in analytical chemistry, molecular biology, and electrochemical sensing with a focus on nucleic acid chemistry and drug delivery systems. His research integrates organic synthesis with bioanalytical techniques, particularly in developing advanced biosensors for genetic analysis and disease diagnostics. His work spans areas such as real-time DNA imaging in live cells, electrochemical detection of single nucleotide polymorphisms (SNPs), and the design of lipid-linked nucleotides for membrane anchoring. He has also explored betulinic acid derivatives for anticancer and anti-HIV applications, as well as bimodal drug delivery systems for photodynamic therapy. Dr. Kodr’s recent publications emphasize innovations in biosensor development, including solid-phase recombinase polymerase amplification and ferrocene-labeled nucleotides for SNP detection in tuberculosis. His research contributes to both fundamental understanding of nucleic acid behavior and practical applications in diagnostics and therapeutics. He is part of the vibrant research community at ETH Zürich’s Department of Chemistry and Applied Biosciences, collaborating on projects that bridge organic synthesis, biochemistry, and engineering. His lab focuses on translating chemical innovations into biomedical solutions with clinical relevance.

• Analytical Chemistry
• Biochemistry
• Molecular Biology
• +3 more

Professor Patrycja Nowak-Sliwinska is a faculty member at the University of Geneva’s Faculty of Pharmaceutical Sciences, where she leads the Cancer Systems Pharmacology group. She holds a PhD from Jagiellonian University (2006) and completed postdoctoral research at EPFL (Switzerland) and VU University Medical Centre (Netherlands). Her habilitation in Biochemistry (2014) and a Marie Curie Fellowship (2014) underscore her academic trajectory. In 2016, she secured a prestigious ERC Starting Grant and joined UNIGE as an Assistant Professor, later becoming a full Professor. Her lab focuses on optimizing multi-drug combinations using phenotypic testing and data modeling for personalized cancer treatment. Her research integrates molecular pharmacology, angiogenesis inhibition, and photodynamic therapy. Notable contributions include discovering vimentin’s role in tumor angiogenesis and developing liposomal drug formulations. Awards include the ERC Starting Grant (2016) and Marie Curie Fellowship (2014). She chairs the Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO) and contributes to CRTOH and Science Innovation Hub governance. Her 90+ publications and four patents highlight her impact in cancer systems pharmacology. Current projects explore drug resistance mechanisms in colorectal and renal cancers, leveraging organoid models and computational approaches.

• Cancer Systems Pharmacology
• Drug Combination Therapy
• Personalized Medicine
• +3 more